Table 2.
Mass of key organs and artery characteristics
Age (months) | ||||||||
---|---|---|---|---|---|---|---|---|
Control | DMB | |||||||
5 | 18 | 21 | 24 | 27 | 21 | 24 | 27 | |
Mass of key organs | ||||||||
Heart mass (mg) | 134 ± 9 | 174 ± 17* | 167 ± 24* | 166 ± 23* | 170 ± 28* | 150 ± 15 | 178 ± 22 | 171 ± 25 |
Brain mass (mg) | 397 ± 47 | 429 ± 41 | 450 ± 73 | 468 ± 43* | 445 ± 46* | 398 ± 78 | 418 ± 41 | 434 ± 50 |
Lung mass (mg) | 165 ± 19 | 192 ± 18 | 196 ± 32 | 209 ± 41* | 227 ± 25* | 183 ± 48 | 195 ± 30 | 214 ± 41 |
Liver mass (g) | 1.56 ± 0.21 | 1.99 ± 0.64 | 1.77 ± 0.35 | 1.62 ± 0.44 | 1.59 ± 0.59 | 1.50 ± 0.20 | 1.44 ± 0.45 | 1.73 ± 0.70 |
Kidney mass (mg) | 395 ± 66 | 452 ± 45 | 458 ± 70 | 432 ± 96 | 441 ± 47 | 446 ± 45 | 475 ± 54 | 461 ± 55 |
Spleen mass (mg) | 72 ± 8 | 75 ± 13 | 84 ± 19 | 85 ± 38 | 106 ± 45 | 64 ± 9 | 92 ± 35 | 100 ± 52 |
Visceral fat mass (g) | 0.98 ± 0.42 | 1.74 ± 0.95* | 1.17 ± 0.79 | 0.79 ± 0.57 | 0.42 ± 0.25* | 0.72 ± 0.58 | 0.30 ± 0.29 | 0.21 ± 0.15 |
Artery characteristics (resting) | ||||||||
Carotid artery | 447 ± 31 | 467 ± 18 | 486 ± 46 | 464 ± 79 | 488 ± 37 | 480 ± 28 | 491 ± 36 | 500 ± 53 |
diameter (μm) | ||||||||
Aorta diameter (μm) | 625 ± 20 | 611 ± 35 | 662 ± 45 | 653 ± 85 | 716 ± 55* | 631 ± 42 | 741 ± 58 | 706 ± 79 |
Data are mean ± SD. n = 7–20 per age per group. Statistics are one-way (effect of age in control mice only) ANOVA with Dunnett’s post hoc test and two-way mixed (age × treatment group) ANOVA with Šídák’s post hoc test.
P < 0.05 control vs. 5 month reference group.
P < 0.05 DMB vs. control within time point. Abbreviations: DMB, 3,3-dimethyl-1-butanol.